The colleagues of Morris et al.10 detected a sensitivity of 86% for linear measurements compared to volumetric MRI measurements in 61 NF2-associated VS on Bevacizumab using a 2-mm threshold to define a tumor progression. This evidence concerns the gene NF2 and neoplasm.